A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010

Trial Identifier: PT010011
Sponsor: Pearl Therapeutics, Inc.
NCTID:: NCT03311373
Start Date: October 2017
Primary Completion Date: December 2017
Study Completion Date: December 2017
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
US, MD Baltimore, MD, US, 21201